# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA961621 | B | Inhibition of PLA2g7 in mouse brain assessed as reduction in spectral count at 5 uM treated for 30 mins by ABPP-MudPIT assay relative to control | Mus musculus | 1 | tissue-based format | Scientific Literature | ||
2. | ALA961622 | B | Inhibition of PLA2g7 in mouse brain assessed as reduction in spectral count at 50 uM treated for 30 mins by ABPP-MudPIT assay relative to control | Mus musculus | 1 | tissue-based format | Scientific Literature | ||
3. | ALA961626 | B | Inhibition of PLA2g7 in mouse brain by LC-MS analysis | Mus musculus | 1 | tissue-based format | Scientific Literature | ||
4. | ALA1794466 | B | PUBCHEM_BIOASSAY: Late stage assay provider results from the probe development effort to identify inhibitors of plasma platelet activating factor acetylhydrolase (pPAFAH): fluorescence-based dose response biochemical gel-based competitive Activity-Based Protein Profiling (ABPP) assay for HTS compounds. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463082, AID463092, AID463230, AID588474] | 2 | cell-free format | PubChem BioAssays | |||
5. | ALA2114854 | F | PubChem BioAssay. Late stage assay provider results from the probe development effort to identify inhibitors of pPAFAH: fluorescence-based dose-response biochemical gel-based competitive Activity-Based Protein Profiling (ABPP) assay for SAR compounds. (Class of assay: confirmatory) | Mus musculus | 5 | assay format | PubChem BioAssays | ||
6. | ALA3635116 | B | Invivo inhibition of Lp-PLA2 in mouse plasma at 100 nM after 24 hrs | Mus musculus | 4 | single protein format | Scientific Literature | ||
7. | ALA3635117 | B | Inhibition of Lp-PLA2 in mouse plasma at 1 uM using 2-thio-PAF substrate after 10 mins | Mus musculus | 8 | single protein format | Scientific Literature |